Exclusive | Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million - WSJ
Sentiment Mix
Geography
Expert Signals
Politics - Google News US Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Exclusive | Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million - WSJ.
Supported by 1 story
Exclusive | Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million WSJLigand Pharmaceuticals to buy XOMA Royalty in $740M all-cash deal: WSJ MSNLigand Pharmaceuticals (LGND) Announces $740 Million Acquisition Deal GuruFocusLigand to buy XOMA Royalty (Nasdaq: XOMA) in $739M cash and CVR deal Stock TitanLigand to Acquire XOMA Royalty, Further Accelerating Profit GlobeNewswire
Supported by 1 story
Related Events
'Michael' moonwalks to $97 million opening, shattering record for music biopics - ABC News - Breaking News, Latest News and Videos
Industry • 4/27/2026
Stock Market Today: Dow, S&P 500 Move Higher; Oil Climbs — Live Updates - WSJ
Industry • 4/27/2026
2026 NFL Mock Draft Grades: Scoring the Experts - Bleeding Green Nation
Industry • 4/27/2026
Rogers Communications offering buyouts to half its work force - The Globe and Mail
Uncategorized • 4/27/2026
iPhone Ultra and MacBook Ultra are coming this year, per report - 9to5Mac
Product Launch • 4/27/2026
Causality Chain
Preceded By
Led To
Stock Market Today: Dow, S&P 500 Move Higher; Oil Climbs — Live Updates - WSJ
46 causal score
'Michael' moonwalks to $97 million opening, shattering record for music biopics - ABC News - Breaking News, Latest News and Videos
45 causal score
2026 NFL Mock Draft Grades: Scoring the Experts - Bleeding Green Nation
45 causal score